- Home
- Publications
- Publication Search
- Publication Details
Title
RNA Interference in the Treatment of Colon Cancer
Authors
Keywords
Epidermal Growth Factor Receptor, Colon Cancer, Colon Cancer Cell, Colon Cancer Cell Line, LoVo Cell
Journal
BIODRUGS
Volume 27, Issue 4, Pages 317-327
Publisher
Springer Nature
Online
2013-04-03
DOI
10.1007/s40259-013-0019-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted Delivery of Small Interfering RNA Using Reconstituted High-Density Lipoprotein Nanoparticles
- (2015) Mian M.K. Shahzad et al. NEOPLASIA
- Carbohydrate Markers in Colon Carcinoma
- (2013) Sławomir Dariusz Szajda et al. DISEASE MARKERS
- Tumor-Derived Chemokine CCL5 Enhances TGF- -Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory Cells
- (2012) L.-Y. Chang et al. CANCER RESEARCH
- Msi-1 is a Predictor of Survival and a Novel Therapeutic Target in Colon Cancer
- (2011) Dawei Li et al. ANNALS OF SURGICAL ONCOLOGY
- Inhibition of STAT3 by RNA interference suppresses angiogenesis in colorectal carcinoma
- (2011) W.F. Qian et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- STAT3 Is Necessary for Proliferation and Survival in Colon Cancer-Initiating Cells
- (2011) L. Lin et al. CANCER RESEARCH
- Suppression of mucin 2 enhances the proliferation and invasion of LS174T human colorectal cancer cells
- (2011) Xiaodong Bu et al. CELL BIOLOGY INTERNATIONAL
- Cyclooxygenase as a Target for Colorectal Cancer Chemoprevention
- (2011) Leticia Moreira et al. CURRENT DRUG TARGETS
- USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1
- (2011) Boyko S Atanassov et al. EMBO REPORTS
- Profile of protein expression of the colon cancer cell line SW480 with survivin/shRNA
- (2011) Xuehu Wang et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Role of Rho GTPases and their regulators in cancer progression
- (2011) Rajamani Rathinam Frontiers in Bioscience-Landmark
- Knock-down of ubiquitin-specific protease 22 by micro-RNA interference inhibits colorectal cancer growth
- (2011) Hui Xu et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Endosomal Accumulation of the Activated Epidermal Growth Factor Receptor (EGFR) Induces Apoptosis
- (2011) Jamie S. Rush et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Potential of Osteopontin as a Therapeutic Target for Human Colorectal Cancer
- (2011) Wang Likui et al. JOURNAL OF GASTROINTESTINAL SURGERY
- High nuclear expression of STAT3 is associated with unfavorable prognosis in diffuse large B-cell lymphoma
- (2011) Wu ZL et al. Journal of Hematology & Oncology
- Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer
- (2011) Xiao-Yuan Chu et al. JOURNAL OF SURGICAL ONCOLOGY
- CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells
- (2011) Claudia Rubie et al. Journal of Translational Medicine
- Small Interfering RNA for Effective Cancer Therapies
- (2011) X. Wang et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Unknown
- (2011) Lei Jiang et al. MOLECULAR MEDICINE
- A Double-modulation Strategy in Cancer Treatment With a Chemotherapeutic Agent and siRNA
- (2011) Kazuya Nakamura et al. MOLECULAR THERAPY
- Current prospects for RNA interference-based therapies
- (2011) Beverly L. Davidson et al. NATURE REVIEWS GENETICS
- RNAi-Mediated Knock-Down of Arylamine N-acetyltransferase-1 Expression Induces E-cadherin Up-Regulation and Cell-Cell Contact Growth Inhibition
- (2011) Jacky M. Tiang et al. PLoS One
- C-Terminal Substitution of MDM2 Interacting Peptides Modulates Binding Affinity by Distinctive Mechanisms
- (2011) Christopher J. Brown et al. PLoS One
- EZH2 Depletion Blocks the Proliferation of Colon Cancer Cells
- (2011) Bettina Fussbroich et al. PLoS One
- Secreted Osteopontin Is Highly Polymerized in Human Airways and Fragmented in Asthmatic Airway Secretions
- (2011) Mehrdad Arjomandi et al. PLoS One
- Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR
- (2011) Anastasia Pavlidou WORLD JOURNAL OF GASTROENTEROLOGY
- Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells
- (2011) Jinsong Yang et al. World Journal of Surgical Oncology
- Nucleocytoplasmic shuttling of hexokinase II in a cancer cell
- (2010) Catherine L. Neary et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells
- (2010) A Strillacci et al. BRITISH JOURNAL OF CANCER
- Knockdown of RCK/p54 expression by RNAi inhibits proliferation of human colorectal cancer cells in vitro and in vivo
- (2010) Fang Lin et al. CANCER BIOLOGY & THERAPY
- Hacking hexokinase halts tumor growth
- (2010) Yongjun Fan et al. CANCER BIOLOGY & THERAPY
- FOXQ1 Is Overexpressed in Colorectal Cancer and Enhances Tumorigenicity and Tumor Growth
- (2010) H. Kaneda et al. CANCER RESEARCH
- RNA interference-mediated silencing of UBCH10 gene inhibits colorectal cancer cell growthin vitroandin vivo
- (2010) Shi-Min Chen et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Implication of USP22 in the Regulation of BMI-1, c-Myc, p16INK4a, p14ARF, and Cyclin D2 Expression in Primary Colorectal Carcinomas
- (2010) Yanlong Liu et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Estimates of cancer incidence and mortality in Europe in 2008
- (2010) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Potential clinical applications of siRNA technique: benefits and limitations
- (2010) Shao-Hua Chen et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo
- (2010) Haibo Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer
- (2010) Yan Long Liu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Blocking effects of siRNA on VEGF expression in human colorectal cancer cells
- (2010) Yu Yin WORLD JOURNAL OF GASTROENTEROLOGY
- Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate
- (2009) Zhao Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis
- (2009) N Miyoshi et al. BRITISH JOURNAL OF CANCER
- Survivin: a potential prognostic marker and chemoradiotherapeutic target for colorectal cancer
- (2009) C. Xiaoyuan et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Oncolytic adenovirus mediated Survivin knockdown by RNA interference suppresses human colorectal carcinoma growth in vitro and in vivo
- (2009) Wei Shen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Inhibitory effects of adenovirus mediated tandem expression of RhoA and RhoC shRNAs in HCT116 cells
- (2009) Xiang-ping Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Activation of the Enhancer of Zeste Homologue 2 Gene by the Human Papillomavirus E7 Oncoprotein
- (2008) D. Holland et al. CANCER RESEARCH
- MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells
- (2008) Antonio Strillacci et al. EXPERIMENTAL CELL RESEARCH
- Knockdown of RNA Binding Protein Musashi-1 Leads to Tumor Regression In Vivo
- (2008) Sripathi M. Sureban et al. GASTROENTEROLOGY
- UbcH10 has a rate-limiting role in G1 phase but might not act in the spindle checkpoint or as part of an autonomous oscillator
- (2008) A. Walker et al. JOURNAL OF CELL SCIENCE
- In vivo optical imaging of human lymphoma xenograft using a library-derived peptidomimetic against 4 1 integrin
- (2008) L. Peng et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More